Month: November 2022

Nov 09 2022

Uncategorized

Genetic Mechanism Linking Dopamine to Schizophrenia Revealed

by Clinical Editor

No Comments

Researchers have identified how the brain chemical dopamine associates with schizophrenia. Schizophrenia, a devastating brain disorder is characterized by delusional thinking, hallucinations and other …

Nov 08 2022

Uncategorized

Frontal Transcranial Direct Current Stimulation Improves Schizophrenia Symptoms – Psychiatry Advisor

by Clinical Editor

No Comments

Frontal Transcranial Direct Current Stimulation Improves Schizophrenia Symptoms  Psychiatry Advisor Motivating and Empowering Patients With Schizophrenia  Psychiatric Times Schizophrenia Symptoms, Negative Symptoms, and Role Functioning  Physician’s Weekly When one is a caregiver to...

Nov 08 2022

Uncategorized

First Admission Length for Schizophrenia Predicts Antipsychotic Choice

by Clinical Editor

No Comments

Younger age (OR 0.97, 95% CI 0.95-0.99, P =0.01) predicted which patients received LAI antipsychotic treatment, reported Emily Groenendaal, MD, of the New York Medical College in Valhalla. Length of...

Nov 08 2022

Uncategorized

Schizophrenia as an Invisible Illness

by Clinical Editor

No Comments

There is a powerful stigma that people with schizophrenia are always in a state of psychosis and cannot fit into regular society. The reality is that schizophrenia looks very different...

Nov 08 2022

Uncategorized

Schizophrenia: Scientists may have finally solved a 70-year riddle

by Clinical Editor

No Comments

Scientists from the Lieber Institute for Brain Development claim that they’ve solved a 70-year-old-riddle about schizophrenia. Challenged the scientists over decades, they revealed the brain chemical …

Nov 08 2022

Uncategorized

$12.53 Billion Growth for Schizophrenia Drugs Market Size to Hit 5.8% CAGR by 2031

by Clinical Editor

No Comments

According to the report published by Allied Market Research, the global schizophrenia drugs market generated $7.16 billion in 2021 and is estimated to hit $12.53 billion by 2031, registering a...

Nov 08 2022

Uncategorized

What is the relationship between Asperger’s and schizophrenia?

by Clinical Editor

No Comments

Asperger’s and schizophrenia are both neurodevelopmental disorders. Although they are different conditions, some symptoms may overlap. Read more here.

Nov 07 2022

Uncategorized

Schizophrenia as an Invisible Illness

by Clinical Editor

No Comments

There is a powerful stigma that people with schizophrenia are always in a state of psychosis and cannot fit into regular society. The reality is that schizophrenia looks very different...

Nov 07 2022

Uncategorized

Schizophrenia: Scientists may have finally solved a 70-year riddle

by Clinical Editor

No Comments

Scientists from the Lieber Institute for Brain Development claim that they’ve solved a 70-year-old-riddle about schizophrenia. Challenged the scientists over decades, they revealed the brain chemical …

Nov 07 2022

Uncategorized

$12.53 Billion Growth for Schizophrenia Drugs Market Size to Hit 5.8% CAGR by 2031

by Clinical Editor

No Comments

According to the report published by Allied Market Research, the global schizophrenia drugs market generated $7.16 billion in 2021 and is estimated to hit $12.53 billion by 2031, registering a...